Mayflower Financial Advisors, LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 1852930
BOSTON, MA
Position in GLUE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$242,000
+$77,500 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3
of 5 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in GLUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $1,390,659 across 8 Biotechnology names. GLUE ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,681 | $835,003 | |
| 2 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
10,000 | $242,000 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
20,212 | $176,956 | |
| 4 | HELP |
Cybin Inc.
|
10,290 | $68,016 | |
| 5 | ELTX |
Elicio Therapeutics, Inc.
|
10,000 | $39,100 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
|
12,559 | $13,814 | |
| 7 | GNPX |
Genprex, Inc.
|
20,000 | $10,380 | |
| 8 | GTBP |
GT Biopharma, Inc.
|
11,000 | $5,390 |
All Filings in GLUE
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,000 | 10,000 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $164,500 | 10,000 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $156,800 | 10,000 | Shares | Sole | 2026-01-13 | |
| No filing history on record for this holder in this stock. | ||||||